European EV Sales Surge in April 2026 as Tesla and Chinese Automakers Gain Ground 
U.S. Launches New Strikes on Iran as Trump Signals Peace Deal Uncertainty 
UK Grocery Inflation Slows to 3.1% as Supermarket Price Pressures Ease in May 2026 
Canada and Germany Advance Major LNG Supply Partnership 
S&P 500, Nasdaq Hit Record Highs as Iran Ceasefire Talks and AI Rally Boost Markets 
Asian Stocks Rally as AI Boom and Iran Ceasefire Progress Lift Market Sentiment 
Oil Prices Set for Sharp Weekly Losses as U.S.-Iran Ceasefire Hopes Ease Supply Concerns 
Oil Prices Jump After New U.S. Strikes on Iran Raise Supply Concerns 
Iran-U.S. Nuclear Talks Remain Unresolved as Strait of Hormuz Risks Keep Markets on Edge 
Mega IPOs Like SpaceX and OpenAI Could Reshape S&P 500 and Nasdaq 100 Portfolios in 2026 
US Dollar Slips as Markets Weigh Potential US-Iran Peace Deal and Oil Price Outlook 
South Korea Central Bank Holds Interest Rates Steady Amid Inflation Concerns 
European Stocks Rise as AI Optimism Offsets U.S.-Iran Tensions 
US Launches New Trade Investigation Into Vietnam Over Intellectual Property Concerns 
US Imposes Fresh Iran Oil Sanctions Despite Progress on Ceasefire Talks 
Dollar Gains Slightly as U.S.-Iran Tensions Keep Forex Markets on Edge 
ECB’s Philip Lane Warns Middle East Conflict Could Keep Inflation Elevated 
Olympus Corp CEO Resigns Following Allegations
Olympus Corp, the renowned Japanese endoscope manufacturer, announced on Monday that Chief Executive Officer Stefan Kaufmann has resigned after allegations surfaced regarding his purchase of illegal drugs. This development has caused a 6% decline in the company's shares, marking the steepest drop in nearly three months.
Kaufmann, a German national, took over the CEO role in April 2023 intending to enhance Olympus's medical equipment division. He succeeded Yasuo Takeuchi, who had successfully navigated the company through extensive asset sales during his tenure.
In a company statement, Olympus disclosed that upon receiving the allegations against Kaufmann, it promptly consulted with external legal counsel and launched an investigation. The investigation's findings led the Board of Directors to unanimously conclude that Kaufmann likely engaged in behavior contrary to the company's global code of conduct and core values.
Kaufmann, 56, was asked to resign and complied with the request. As Olympus grapples with this latest scandal, Yasuo Takeuchi will temporarily reassume the CEO role.
The impact of Kaufmann's departure was evident in the stock market, as Olympus shares have seen a notable increase of 35% over the past year, outperforming the Nikkei 225 index, which rose by 24%.
This incident is not Olympus's first encounter with controversy; thirteen years ago, former CEO Michael Woodford exposed significant accounting fraud involving inflated acquisition costs to conceal financial losses. Woodford's subsequent firing sparked a turbulent battle for control of the company.
